(Q34825627)

4 August 2017

1 reference

title

Malaria: a rising incidence in the United States (English)

1 reference

4 August 2017

0 references

United States of America

0 references

2

Joshua S Broder

1 reference

4 August 2017

David A Jerrard

1

1 reference

4 August 2017

Jeahan R Hanna

3

1 reference

4 August 2017

James E Colletti

4

1 reference

4 August 2017

Katherine A Grundmann

5

1 reference

4 August 2017

Adam J Geroff

6

1 reference

4 August 2017

Amal Mattu

7

1 reference

4 August 2017

language of work or name

1 reference

1 July 2002

1 reference

Journal of Emergency Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

23

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

23-33

1 reference

Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Persistence of Plasmodium falciparum in the placenta after apparently effective quinidine/clindamycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Effects of Plasmodium vivax malaria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

The problem of malaria and malaria control in pregnancy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Rates and risk factors for mortality during the first two years of life in rural Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Malaria imported into the United Kingdom in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Imported malaria in Germany in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Non-microscopic methods for diagnosis of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Diagnosis of malaria: a review of alternatives to conventional microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Accuracy of routine laboratory diagnosis of malaria in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Accuracy of a rapid immunochromatographic card test for Plasmodium falciparum in a malaria control programme in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Comparative evaluation of four techniques for the diagnosis of Plasmodium falciparum infections

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

The ParaSight-F dipstick test as a routine diagnostic tool for malaria in Sri Lanka

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Detecting Plasmodium falciparum in community surveys: a comparison of Paracheck Pf® Test and ICT Malaria Pf® Cassette Test to polymerase chain reaction in Mutasa District, Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

The ParaSight-F test: a simple rapid manual dipstick test to detect Plasmodium falciparum infection

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Malaria diagnosis by field workers using an immunochromatographic test

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Trial of the ParaSight-F test for malaria diagnosis in the primary health care system, Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Post treatment sensitivity studies with the ParaSight-F test for malaria diagnosis in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

False positive dipstick test for malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Lactate dehydrogenase and the diagnosis of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Parasite-specific lactate dehydrogenase for the diagnosis of Plasmodium falciparum infection in an endemic area in west Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Screening for malaria by determination of parasite-specific lactate dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

False-positive rapid tests for malaria in patients with rheumatoid factor

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Field evaluation of a polymerase chain reaction-based nonisotopic liquid hybridization assay for malaria diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Epidemiology of drug resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Mefloquine resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Long-term malaria prophylaxis with weekly mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Chemotherapy and prevention of drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Vivax malaria resistant to chloroquine: case reports from Bombay

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Development of resistance to chloroquine by Plasmodium vivax in Myanmar

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Vivax malaria resistant to treatment and prophylaxis with chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Mefloquine-resistant falciparum malaria on the Thai-Burmese border

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Cardiac effects of antimalarial treatment with halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Therapeutic efficacy of clindamycin in combination with quinine for treating uncomplicated malaria in a village dispensary in Gabon.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Artemisinin: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Failure of mefloquine chemoprophylaxis for malaria in Somalia

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Comparison of the cost-effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Malaria vaccine development: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Malaria vaccines: are seven antigens better than one?

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900457-2

7 January 2021

10.1016/S0736-4679(02)00457-2

Identifiers

DOI

1 reference

release_6nnjmunhk5aqdnk7e5x5dnxijm

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6nnjmunhk5aqdnk7e5x5dnxijm

24 November 2022

mapped directly with Wikidata item

1 reference